Can You Get Cancer on Your Finger? Signs and Types

Cancer can and does develop on the fingers, though it is uncommon enough that both patients and doctors often miss it. The types range from skin cancers growing on the nail bed or fingertip to rare bone tumors inside the finger itself, and in unusual cases, cancer from a distant organ can even spread to a finger bone. Because these tumors are so unexpected in that location, they are frequently mistaken for warts, fungal infections, or stubborn eczema, sometimes for months or years before anyone thinks to biopsy.

Types of Cancer That Occur on the Fingers

Several distinct cancers can arise in or on a finger. They differ in where they start, how they look, and how aggressively they behave.

• Squamous cell carcinoma (SCC): The most common malignant tumor of the nail unit. It typically originates beneath the nail plate and grows slowly. Roughly 57 to 71 percent of nail-unit SCC cases are the subungual type (under the nail), while about 27 to 31 percent are periungual, meaning they grow on the skin folds around the nail.¹ A strong link exists between high-risk strains of human papillomavirus (HPV) and SCC of the nail, a connection that holds in people with both healthy and suppressed immune systems.²
• Subungual melanoma: A rare form of melanoma that develops in the nail matrix, the tissue beneath the base of the nail. It poses particular diagnostic challenges because of the complex anatomy of the nail unit.³ Its prognosis depends heavily on tumor size, depth of infiltration, and clinical stage at diagnosis.⁴
• Basal cell carcinoma (BCC): Common on sun-exposed areas like the face and neck, but rare on the fingers, accounting for only about 0.5 to 2.5 percent of all BCC cases. When it does appear on a finger, the thumb is the favored site, making up about 44 percent of reported finger BCC cases.⁵ The average age of onset is around 67, and men are affected about three times more often than women.
• Epithelioid sarcoma: A rare soft tissue cancer that often starts under the skin of the finger, hand, or forearm. Unlike the cancers listed above, it tends to strike younger people, from teenagers through middle-aged adults.⁶ In a surgical series of cases involving the distal upper extremity, the wrist was the most common site, but fingers accounted for about 17 percent.⁷
• Chondrosarcoma: The most common primary malignant bone tumor of the hand. Most cartilage tumors in finger bones are benign enchondromas, but occasionally one turns out to be a low-grade chondrosarcoma, which can present as a slowly enlarging mass at a finger joint.⁸⁹

There is also a vanishingly rare malignant variant of the glomus tumor, called a glomangiosarcoma, that can appear as a painful nodule under the skin of a fingertip. It tends to be low-grade but can recur locally, and metastasis has been reported in rare instances.¹⁰

Warning Signs You Should Not Ignore

The symptoms vary depending on the cancer type, but a few patterns come up repeatedly across the literature.

For nail-unit SCC, the most common visible change is onycholysis, where the nail plate lifts away from the nail bed. You may also notice redness, a warty or thickened area along the nail fold, or a nodule growing under or beside the nail. Late signs include oozing, ulceration, and pain, the last of which tends to indicate the tumor has reached bone.¹¹¹

For subungual melanoma, the earliest clue in most cases is melanonychia striata, a dark longitudinal streak running the length of the nail. A Japanese clinical series found that the initial sign of the disease was confirmed to be melanonychia striata in the majority of patients studied. Streaks that should prompt concern tend to appear for the first time in adulthood, are wider than about 6 millimeters, show irregular or variegated coloring (or are homogeneously black), and are accompanied by pigment spreading onto the skin around the nail, a feature known as the Hutchinson sign.¹²

For BCC on a finger, the nodular subtype is the most frequently reported. In a review of 27 published cases, nodular BCC accounted for about 19 percent, followed by the infiltrative subtype at around 11 percent.⁵ A pearly or translucent bump on the finger that does not heal should be evaluated.

Epithelioid sarcoma can be deceptive. It often appears as a small, firm nodule under the skin that could easily be mistaken for a cyst or callus. Since it tends to affect younger people who are not thinking about cancer, it can go undiagnosed for a long time.

The Hutchinson Sign and Its Limits

If you read about nail melanoma, you will encounter the Hutchinson sign, the spread of dark pigment from the nail onto the surrounding cuticle and skin folds. It has long been taught as a hallmark of subungual melanoma because it suggests the melanoma is growing radially. Dermatologists generally recommend a biopsy whenever they see it.¹³

That said, the Hutchinson sign is not proof of melanoma. Periungual pigmentation can show up with benign melanocyte activation, drug reactions, fungal infection, and other causes. A dedicated reappraisal of “non-melanoma Hutchinson sign” cases found that the mere presence of periungual pigmentation is neither clinically nor histologically exclusive to melanoma.¹⁴ This is especially true in children, where the clinical and dermoscopic criteria validated for adults have not been confirmed. Still, the overlap is exactly why biopsy matters: you cannot distinguish the dangerous version from the harmless version by looking.

Why Finger Cancer Gets Misdiagnosed

One reason these cancers are so tricky is that they look like ordinary things. SCC on the fingertip or finger pad mimics chronic dermatitis, a wart, an epidermoid cyst, or a stubborn infection. One review noted that the diagnosis of ventral finger SCC is often not initially suspected by the patient or the clinician.¹⁵ The connection between HPV and nail SCC adds to the confusion, because warts and early SCC can look nearly identical under the nail. A wart that persists for years, bleeds, or does not respond to standard treatment deserves a biopsy.

Benign lumps on the hand are also far more common than malignant ones, which breeds complacency. A retrospective study of 80 patients with subcutaneous hand tumors found the most common diagnoses were lipoma, schwannoma, glomus tumor, and epidermal inclusion cyst, all benign.¹⁶ Malignant tumors of the upper limb altogether account for fewer than 3 percent of upper limb tumors. Those odds mean a lump on a finger is almost certainly benign, but “almost certainly” is not the same as “always,” and the stakes of the miss are high.

Dermoscopy, including intraoperative dermoscopy performed during a nail biopsy, has improved accuracy in recent years. Looking directly at the nail matrix after removing the nail plate can help a dermatologist target the right spot for biopsy and better assess how far a tumor has spread.¹⁷¹⁸

Risk Factors Worth Knowing

Different finger cancers have different risk profiles, but a few themes emerge. For SCC, the major risk factors include exposure to high-risk HPV strains, immune suppression (from organ transplant drugs or HIV, for instance), chronic trauma or scarring on the digit, radiation exposure, and occupational contact with certain carcinogens.¹⁵ The HPV connection is significant: Bowen’s disease of the nail (a very early, in-situ form of SCC) has been clearly associated with high-risk HPV types.¹⁹

For melanoma, the risk profile is less clear-cut. Subungual melanoma does not follow the same sun-exposure pattern as other melanomas. It is proportionally more common among people with darker skin, where it makes up a larger share of melanoma cases overall. A dark streak appearing for the first time in adulthood is the single most important warning sign, as noted earlier.

For BCC on the fingers, the average onset age around 67 and the strong male predominance suggest cumulative occupational or sun exposure plays a role, but the numbers are so small that firm conclusions are difficult to draw.

When a Finger Tumor Is Actually Cancer From Somewhere Else

Occasionally, a painful swelling in a finger turns out not to be a primary tumor at all but a metastasis from a cancer elsewhere in the body. These acrometastases, as they are called, are extremely rare and easy to misdiagnose because they mimic infection, gout, or a benign bone cyst. When finger metastases do occur, the lungs are the most frequent source.²⁰ Kidney and breast cancers are the next most common origins.²¹

In some cases, the finger lesion is the first sign that a cancer exists at all. One case report described an index finger acrometastasis that turned out to be the presenting symptom of lung cancer.²² This means persistent, unexplained finger pain or swelling, especially in someone with risk factors for lung or kidney cancer, warrants imaging beyond just an X-ray of the hand.

Treatment and the Question of Amputation

The general principle in treating finger cancer is to cure the disease while preserving as much function and appearance as possible.²³ What that looks like in practice depends on the type of cancer, its stage, and whether bone is involved.

For nail-unit SCC that has not invaded bone, functional surgery (removing the tumor while preserving the finger structure) is increasingly favored over amputation. A systematic review found that recurrence rates after functional surgery and amputation did not differ significantly, supporting functional surgery as a reasonable first-line approach. Amputation is reserved for cases where clean margins cannot be achieved or when bone is already affected.²⁴

For melanoma and sarcoma of the finger, the surgical decisions can be more involved. Melanoma depth and stage at diagnosis are the main drivers of how aggressive surgery needs to be. Fortunately, advances in imaging, staging, and adjuvant therapies have made limb-sparing surgery feasible in the majority of upper limb malignancies overall.

When advanced melanoma arises on the fingers or other acral sites, immunotherapy with checkpoint inhibitors has become the frontline systemic treatment. Anti-PD-1 therapy, alone or combined with anti-CTLA-4 agents, is used for metastatic acral lentiginous melanoma.²⁵ However, acral melanoma tends to have a lower rate of BRAF mutations compared to melanoma from sun-exposed skin, which limits the usefulness of BRAF and MEK targeted therapies for many patients.²⁶ A multicenter registry study found that overall survival in patients with metastatic acral melanoma treated with first-line checkpoint inhibitors trended shorter compared to other cutaneous melanoma types, with median survival of about 18 months versus roughly 44 months.²⁷ The evidence base for these treatments in acral melanoma specifically remains thinner than for more common melanoma subtypes, and larger studies are needed.

Life After Finger Amputation

When amputation is unavoidable, the functional and psychological consequences deserve honest acknowledgment. Losing part of a finger affects grip, dexterity, and fine motor tasks, but it also affects how people feel about their bodies and how they interact socially. Research on digital amputation has found that loss of function, persistent pain, and visible deformity are all directly correlated with poorer patient-assessed outcomes. Upper extremity amputees experience psychological disturbances roughly 50 to 100 percent more often than lower extremity amputees, in part because hands are so central to communication and social interaction.²⁸

This is part of why surgeons are so motivated to pursue finger-sparing approaches when the oncology allows it. Custom silicone prosthetic fingers can restore a more normal appearance, and occupational therapy helps patients adapt grip patterns. But the psychological dimension is real and often underappreciated in follow-up care.

When to See a Doctor

Any of the following changes on a finger should prompt a visit to a dermatologist or hand specialist rather than a wait-and-see approach:

• A new dark streak under a nail: Especially if it appears in adulthood, is wider than a few millimeters, has uneven color, or shows pigment spreading onto surrounding skin.
• A wart that will not go away: Periungual warts are common, but one that persists for years, grows despite treatment, bleeds, or ulcerates should be biopsied to rule out SCC.
• A non-healing sore or bump: Any lesion on a finger that does not improve over several weeks, whether it looks like a sore, a pearly nodule, or a thickened area of skin.
• Nail changes without explanation: Onycholysis (the nail lifting off), a new deformity or thickening of the nail, or a subungual mass visible through the nail plate.
• A painless firm lump under the skin: Especially in a younger person, this could be a soft tissue tumor like epithelioid sarcoma masquerading as a benign cyst.
• Unexplained bone pain or swelling: Particularly in a finger joint, with or without a visible mass, and especially in someone with a history of another cancer.

The single most important thing to understand about finger cancer is the cost of delay. Because these tumors are rare and look like common, harmless conditions, the path from first symptom to correct diagnosis is often much longer than it should be. The person most likely to push for a biopsy early is you.